Four times a year Medix publishes the magazine 'MedZine - focus on immuno-oncology' to keep Dutch medical specialists informed on immunological research in oncology. Besides the latest news, knowledge is shared through expert interviews. Magazine editions are published cross-medially, with news items also available via the immuno-oncology news channel in the MedZine News app.
The third edition contains an interview with pulmonary oncologist Dr. Hiltermann about DNA analysis in non-small cell lung carcinoma, with internist-oncologist Dr. van der Veldt about the effectiveness of the PD-1 inhibitor pembrolizumab in urothelial cell carcinoma, with gastro-enterologist Dr Sprengers about the PD-1 inhibitor nivolumab in the hepatocellular carcinoma and with doctor-entrepreneur Drs. Van Belzen about a new DNA test for cervical cancer. There was also a giveaway this time: readers of 'MedZine - focus on immuno-oncology' had the chance to win a boat trip through the Amsterdam canals with the entire partnership!